Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.
Reinsurance Group of America (RGA) has been catching investor attention after a one-month return of about a 9.7% decline and a past three-month move of roughly a 3.3% decline.
With the stock recently closing at about $198.82 and a market value near $13.4 billion, investors are weighing these share price shifts against the company’s current earnings and revenue profile.
See our latest analysis for Reinsurance Group of America.
Over the past year, RGA’s share price return has softened recently despite a positive 1 year total shareholder return of 3.4% and a much stronger 5 year total shareholder return of 73.35%. This suggests momentum has cooled after earlier gains.
If you are reassessing your portfolio after RGA’s recent pullback, this can be a good moment to look at other potential ideas using a focused screener such as 20 top founder-led companies
With RGA trading around US$198.82, carrying a value score of 4 and sitting at a discount to some analyst targets and intrinsic estimates, you have to ask: is this a genuine entry point, or is the market already baking in future growth?
RGA’s most followed narrative sees fair value at about $249.56 versus the recent $198.82 share price, framing the current pullback against longer term earnings power.
RGA is capitalizing on growing insurance demand in Asia and other international markets, as evidenced by robust new business in Hong Kong, Taiwan, Korea, and a record number of asset-intensive transactions across five countries and three continents; this global expansion drives sustained premium growth and strengthens revenue diversification.
Curious what earnings profile and margin path need to hold for that valuation gap to close? The narrative leans heavily on compounded growth, rising profitability and a lower future earnings multiple than many investors might expect. The full story connects these moving parts into a single fair value number.
Result: Fair Value of $249.56 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this narrative can break if rising medical costs pressure margins or if earnings volatility in key U.S. lines keeps investors cautious about RGA’s profitability path.
Find out about the key risks to this Reinsurance Group of America narrative.
With sentiment split between recent share price softness and a popular undervalued narrative, it makes sense to move quickly and stress test the numbers yourself. To see what others are optimistic about right now, take a closer look at the 5 key rewards.